Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB1100442	注射用重组人白介素-2(125Ala)	Recombinant Human Interleukin-2(125Ala)	Lyophilized	Biological Products	Supplementary Application	2012-07-06	哈高科白天鹅药业集团有限公司	Harbin High-Tech Group Baitian'er Pharmaceutical Co Ltd	Certificate Issued	2014-07-24	view
CYSB1100444	注射用重组人白介素-2(125Ala)	Recombinant Human Interleukin-2(125Ala)	Lyophilized	Biological Products	Supplementary Application	2012-07-06	哈高科白天鹅药业集团有限公司	Harbin High-Tech Group Baitian'er Pharmaceutical Co Ltd	Certificate Issued	2014-07-24	view
CYSB1100443	注射用重组人白介素-2(125Ala)	Recombinant Human Interleukin-2(125Ala)	Lyophilized	Biological Products	Supplementary Application	2012-07-06	哈高科白天鹅药业集团有限公司	Harbin High-Tech Group Baitian'er Pharmaceutical Co Ltd	Certificate Issued	2014-07-24	view
CXSS0600058	注射用重组人白介素-2(125Ala)	Recombinant Human Interleukin-2(125Ala)	Lyophilized	Biological Products(1)	New Drug Application	2006-06-02	上海华新生物高技术有限公司	Shanghai Huaxin High Biotechnology Inc	Certificate Issued	2008-09-01	view
CXSB0500075	注射用重组人白介素-2（125Ala）	Recombinant Human Interleukin-2(125Ala)	Lyophilized	Biological Products	Supplementary Application	2005-12-02	北京双鹭药业股份有限公司	Beijing SL Pharmaceutical Co Ltd	Certificate Issued	2006-07-12	view